跳至主要内容
临床试验/NCT02522130
NCT02522130Unknown不适用

Different Analgesics Prior to IUD Insertion: Is There Any Evidence?

Al Hayat National Hospital2 个研究点 分布在 2 个国家目标入组 200 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
200
试验地点
2
主要终点
current pain level with IUD insertion and 15 minutes post procedure measured by the Visual Analogue Scale.

研究概览

简要总结

Different ways of reducing pain during IUD insertion have been explored. So a randomized study will be conducted to test their role

详细描述

A randomized clinical controlled trial of women undergoing IUD insertion. Participants in the study groups will be randomly assigned by labeled opaque envelopes to either1% lidocaine (Xylocaine 1%, Astra Zeneca, Egypt), misoprostol (Sigma, Egypt), naproxen (Naprosyn, Syntax, Egypt) or placebo tablets.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients are considered eligible if:
  • they are alert oriented and co-operative to response to the visual analogue scale (VAS).
  • They will sign the informed consent to participate in the clinical trial before entering the study.
  • Willingness to be randomized and complete study questionnaires.

排除标准

  • Participants are excluded from participation if they are ineligible for an IUD by accepted criteria of our institution such as:
  • A lidocaine allergy
  • Copper allergy
  • Current cervicitis
  • Pelvic inflammatory disease (PID) within 3 months
  • Uterine anomalies
  • Pain medication within 6 hours before insertion
  • Misoprostol administration within 24 hour before insertion
  • History of cervical surgery and contraindication to study medications.

研究组 & 干预措施

lidocaine group

Active Comparator

Group A will receive 10 ml 1% lidocaine (Xylocaine 1%, Astra Zeneca, Egypt) Para cervical block prior to insertion of IUD (injection sites at cervix-vaginal junction typically at 4 ,8 O'clock), Then 3 minutes waiting period between the administration of the Para cervical block and IUD insertion,

干预措施: Lidocaine (Drug)

misoprostol group

Active Comparator

Group B will receive 400 mcg oral misoprostol (Sigma, Egypt) prior to IUD insertion

干预措施: oral misoprostol (Drug)

non steroid group

Active Comparator

Group C will receive oral naproxen (Naprosyn, Syntax, Egypt) prior to IUD insertion

干预措施: naproxen (Drug)

placebo group

Placebo Comparator

group D will receive placebo tablets.

干预措施: placebo (Other)

结局指标

主要结局

current pain level with IUD insertion and 15 minutes post procedure measured by the Visual Analogue Scale.

时间窗: 15 minutes

A Visual Analogue Scale is a measurement instrument that tries to measure a characteristic or attitude that is believed to range to across a continuum of values and can not easily to be directly measured. Subjects pain using a 10 point visual analogue scale (-+VAS, anchors: 0=non, 10 = worst imaginable). The participants were asked to mark their pre IUD insertion pain expectancies initially, then to mark their pain during different steps of IUD placement.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

mohamed maher

assistant professor

Al Hayat National Hospital

研究点 (2)

Loading locations...

相似试验